125
Participants
Start Date
October 1, 2020
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
serum leucine-rich alpha-2 glycoprotein (LRG) levels
Patients who were diagnosed with possible UC or Crohn disease according to endoscopic, radiological, histological, and clinical criteria were enrolled. Serum samples were collected from patients, and scores for clinical and endoscopic activity of disease were obtained by reviewing the clinical records of patients. Serum sampling and colonoscopy were performed within 7 days.
Showa Inan General Hospital, Komagane
Showa Inan General Hospital
OTHER